Human telomerase catalytic subunit: diagnostic and therapeutic methods
US6475789B1 · kind B1 · utility
62Cited by
18References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 14, 1997 |
| Grant date | Nov 5, 2002 |
| Priority date | — |
| Expiry date | Aug 14, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods related to human telomerase reverse transcriptase (hTRT), the catalytic protein subunit of human telomerase. The polynucleotides and polypeptides of the invention are useful for diagnosis, prognosis, and treatment of human diseases, for changing the proliferative capacity of cells and organisms, and for identification and screening of compounds and treatments useful for treatment of diseases such as cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.